Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity

A. H. Brandenburg, R. van Beek, H. A. Moll, A. D. M. E. Osterhaus, E. C. J. Claas
A. H. Brandenburg
Institute of Virology, Erasmus University Hospital, 3000 DR Rotterdam, and the
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. van Beek
Institute of Virology, Erasmus University Hospital, 3000 DR Rotterdam, and the
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. A. Moll
Department of Paediatrics, Sophia Children's Hospital, 3015 GE Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. D. M. E. Osterhaus
Institute of Virology, Erasmus University Hospital, 3000 DR Rotterdam, and the
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. C. J. Claas
Institute of Virology, Erasmus University Hospital, 3000 DR Rotterdam, and the
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.38.10.3849-3852.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Respiratory syncytial virus group A strain variations of 28 isolates from The Netherlands collected during three consecutive seasons were studied by analyzing G protein sequences. Several lineages circulated repeatedly and simultaneously during the respective seasons. No relationships were found between lineages on the one hand and clinical severity or age on the other.

Respiratory syncytial virus (RSV) can be divided into two groups, A and B, on the basis of the reaction with monoclonal antibodies directed against the F and G proteins (1, 23) and nucleotide sequence differences of several genes (5, 16, 30, 31). These two groups circulate independently in the human population, with group A being the most prevalent (14, 23).

Also, within the two groups substantial strain differences have been described, mainly associated with the divergence in the gene encoding the G protein (17), which is the most variable protein of the virus. Several lineages within groups A and B also seem to cocirculate simultaneously in the population (3, 30). Studies on RSV strains show an accumulation of amino acid changes over the years, suggesting antigenic drift-based, immunity-mediated selection (4, 5, 8, 15, 27).

One of the most interesting features of RSV is its ability to cause repeated infections throughout life (9, 11). This enables RSV to remain present at high levels in the population, and it has been estimated that at least 50% of children encounter their first RSV infection during their first winter season. Strain variation is thought to contribute to its ability to cause frequent reinfections (4, 8, 32).

The clinical severity of RSV infection is associated with epidemiological and host factors, which include socioeconomic status (26), age (26), prematurity (25), and underlying heart and/or lung disease (10, 19). Several studies have evaluated differences in clinical severity between groups A and B. In about half of these studies, no differences in clinical severity were detected between the groups involved (14, 18, 21, 22, 28, 34, 37), and in the other studies, group A seemed to be associated with more severe clinical disease (12, 13, 20, 23, 29, 33, 36). It has been suggested that virus variants within group A are responsible for this discrepancy (7, 12, 36).

To further address this issue, we selected group A strains from three consecutive winter seasons and subjected isolates of these strains to sequence analyses of part of the G protein. The strains were isolated from children for whom standardized clinical data were available from a previous study concerning RSV-A versus RSV-B and clinical severity (18).

RSV isolates (n = 293) found in routine diagnostics during three consecutive winter seasons were typed by performing direct immune fluorescence on cells from nasopharyngeal washings using specific monoclonal antibodies MAB 92-11C for group A and MAB 109-10B for group B (Chemicon, Temecula, Calif.) as previously described (2). Twenty-eight RSV group A isolates were selected for sequence analysis.

All five group A strains available from the first season (1992–1993) were included. Eleven from the second season (1993–1994) and twelve from the third season (1994–1995) were selected from children who had experienced either a mild infection (not admitted) or a severe infection as determined by clinical parameters upon admission (see below).

Demographic and clinical data on the children during the acute phase and at the time of the control visit were collected in a previous study (18). Briefly, the data included gender, age, duration of pregnancy, underlying disease, feeding difficulties, history of apnea, the presence of retractions, respiratory rate, oxygen saturation (SaO2) in room air, partial CO2 pressure (pCO2), pH, abnormalities on X rays, admission to an intensive care unit, and the need for artificial ventilation. Severe RSV infection was defined as meeting one or more of the following criteria: pCO2 > 6.6 kPa, SaO2 < 90%, and/or the need for artificial ventilation.

Viral RNA extraction and amplification of the viral RNA by reverse transcriptase PCR were carried out as described previously (35). Briefly, RNA was extracted from 100 μl of culture supernatant using a guanidinium isothiocyanate solution and was collected by precipitation with isopropanol. The viral RNA was then amplified by reverse transcriptase PCR using oligonucleotide primers G(A)-173s (GGCAATGATAATCTCAACTTC) and G(A)-525as (TGAATATGCTGCAGGGTACT), which resulted in an amplified fragment of 392 bp spanning the first hypervariable region of the G protein (amino acids [aa] 100 to 132). The amplified products were subjected to nucleotide sequence analysis by cycle sequencing using an ABI dye terminator sequencing system and analysis on an ABI Prism 377 DNA sequencer (PE Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). Alignment of the nucleotide sequences of the G protein gene of the RSV isolates was carried out using the GCG package (Madison, Wis.). Multiple sequence files were analyzed by DNAPARS in the PHYLIP package (6). Subsequently, phenograms were generated using the DRAWGRAM program.

Clinical data of patients from the respective seasons were compared in a χ2 test, Fisher's exact test, or Mann-Whitney U test when applicable.

During the three winter seasons, 232 children younger than 12 months of age were diagnosed with a RSV infection by direct immune fluorescence and/or virus isolation. In 1992–1993 a predominance of group B viruses was found, season 1993–1994 showed a mixed epidemic, and in season 1994–1995 all children were infected with group A viruses (18). Figure 1 shows the numbers of RSV isolates in The Netherlands per week during the three seasons. In the 1994–1995 season, a short steep peak in the first weeks of December was observed. During this third season, more children younger than 1 month of age were admitted. Children in the third season had a higher mean pCO2 and lower pH (Table1) than children in the first two seasons. No other differences in parameters known to correlate with clinical severity could be objectively measured.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Number of RSV isolates per week during the three seasons studied, as recorded by the combined Dutch Virology Laboratories. (Published with permission of the Dutch Working Group on Clinical Virology.)

View this table:
  • View inline
  • View popup
Table 1.

Clinical parameters of RSV-infected patients during three consecutive seasons

G protein amplicons of 28 RSV group A isolates divided over the three seasons were studied by sequence analysis, and a phenogram was generated (Fig. 2). Season of infection, age upon diagnosis, and clinical parameters—severity score, artificial ventilation, and apnea—are indicated in the phenogram.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Phylogenetic dendrogram showing relatedness of group A isolates determined by sequence analyses of the first hypervariable region of the G protein. Isolates were selected from three consecutive seasons in the Sophia Children's Hospital of Rotterdam. Seasons indicated are as follows: 1, 1992–1993; 2, 1993–1994; 3, 1994–1995. For each isolate, the following patient characteristics are indicated. Severity of RSV infection: s, severe; m, mild. Severe was defined as meeting one or more of the following criteria: pCO2 > 6.6 kPa, SaO2 < 90%, and a need for artificial ventilation. a.v., the need for artificial ventilation; apn., a history of apnea; age, the age in days upon admission.

Several lineages of RSV were found to be present during the three seasons studied, and several lineages could be identified during all three seasons. Closely related strains were also found to occur in subsequent seasons. The observed clustering of the RSV isolates proved to be independent of season or patient-related parameters (Fig. 2).

Thus, several lineages of RSV-A cocirculated during the three seasons studied, and clinically severe as well as milder cases were evenly distributed over the different lineages found.

RSV infections are usually found during several months in the winter season. In the 1994–1995 season, a relatively high incidence of RSV infections during a relatively short period was found. In the 1994–1995 season, more children from the very young age group were admitted. The only clinical parameters objectively found to be more severe in the 1994–1995 season were the pCO2 and the pH. These parameters may be directly related to the younger age of the children involved, since a significant relationship between pCO2 and age has been previously described (24).

The RSV-G protein is the most variable of the RSV proteins; therefore, we chose to sequence a variable part of the RSV-G protein to study strain variation within subgroup A. However, it is not known where in the RSV genome putative virulence factors would be located. Since we sequenced only a small part of the genome, it cannot be fully excluded that mutations important for virulence elsewhere on the RSV genome were missed.

The isolates from the 1994–1995 season were all of group A. We investigated whether this peak represented a single, possibly more virulent, strain of RSV-A. Despite the limited number of strains that were sequenced, it was clear that in the 1994–1995 season, as well as in the other two seasons, several different strains cocirculated, and severe infections or younger age proved not to be related to one particular strain. In addition, closely related strains were found during different seasons, as has been described previously (3, 8, 30).

Collectively, our data show that during a winter season when relatively many children are admitted during a relatively short period, several strains may cocirculate in the population. In addition, it was shown that clinically more severe cases were found spread over the branches of the phylogenetic tree. Therefore, severity of infection could not be attributed to particular lineages of RSV.

ACKNOWLEDGMENTS

We thank Conny Kruyssen for assistance in preparing the manuscript.

FOOTNOTES

    • Received 12 June 2000.
    • Returned for modification 25 July 2000.
    • Accepted 9 August 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson L. J.,
    2. Hierholzer J. C.,
    3. Tsou C.,
    4. Hendry R. M.,
    5. Fernie B. F.,
    6. Stone Y.,
    7. McIntosh K.
    Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.J. Infect. Dis.1511985626633
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Brandenburg A. H.,
    2. Groen J.,
    3. Van Steensel-Moll H. A.,
    4. Claas E. J. C.,
    5. Rothbarth P. H.,
    6. Neijens H. J.,
    7. Osterhaus A. D. M. E.
    Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.J. Med. Virol.52199797104
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Cane P. A.,
    2. Matthews D. A.,
    3. Pringle C. R.
    Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide.Virus Res.2519921522
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Cane P. A.,
    2. Matthews D. A.,
    3. Pringle C. R.
    Analysis of respiratory syncytial virus strain variation in successive epidemics in one city.J. Clin. Microbiol.32199414
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Cane P. A.,
    2. Pringle C. R.
    Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein.J. Virol.69199529182925
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Felsenstein J.
    Phylip-Phylogeny Interference Package.Cladistics51989164166
    OpenUrlCrossRef
  7. 7.↵
    1. Fletcher J. N.,
    2. Smyth R. L.,
    3. Thomas H. M.,
    4. Ashby D.,
    5. Hart C. A.
    Respiratory syncytial virus genotypes and disease severity among children in hospital.Arch. Dis. Child.771997508511
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Garcia O.,
    2. Martin M.,
    3. Dopazo J.,
    4. Arbiza J.,
    5. Frabasile S.,
    6. Russi J.,
    7. Hortal M.,
    8. Perez-Brena P.,
    9. Martinez I.,
    10. Garcia-Barreno B.
    Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.J. Virol.68199454485459
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Glezen W. P.,
    2. Taber L. H.,
    3. Frank A. L.,
    4. Kasel J. A.
    Risk of primary infection and reinfection with respiratory syncytial virus.Am. J. Dis. Child.1401986543546
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Groothuis J. R.,
    2. Gutierrez K. M.,
    3. Lauer B. A.
    Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.Pediatrics821988199203
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Hall C. B.,
    2. Walsh E. E.,
    3. Long C. E.,
    4. Schnabel K. C.
    Immunity to and frequency of reinfection with respiratory syncytial virus.J. Infect. Dis.1631991693698
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Hall C. B.,
    2. Walsh E. E.,
    3. Schnabel K. C.,
    4. Long C. E.,
    5. McConnochie K. M.,
    6. Hildreth S. W.,
    7. Anderson L. J.
    Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.J. Infect. Dis.162199012831290
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Heikkinen T.,
    2. Waris M.,
    3. Ruuskanen O.,
    4. Putto-Laurila A.,
    5. Mertsola J.
    Incidence of acute otitis media associated with group A and B respiratory syncytial virus infections.Acta Paediatr.841995419423
    OpenUrlPubMedWeb of Science
  14. 14.↵
    1. Hendry R. M.,
    2. Talis A. L.,
    3. Godfrey E.,
    4. Anderson L. J.,
    5. Fernie B. F.,
    6. McIntosh K.
    Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks.J. Infect. Dis.1531986291297
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Johansen J.,
    2. Christensen L. S.,
    3. Hornsleth A.,
    4. Klug B.,
    5. Hansen K. S.,
    6. Nir M.
    Restriction pattern variability of respiratory syncytial virus during three consecutive epidemics in Denmark.APMIS1051997303308
    OpenUrlPubMedWeb of Science
  16. 16.↵
    1. Johnson P. R.,
    2. Spriggs M. K.,
    3. Olmsted R. A.,
    4. Collins P. L.
    The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.Proc. Natl. Acad. Sci. USA84198756255629
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Johnson P. R. Jr.,
    2. Olmsted R. A.,
    3. Prince G. A.,
    4. Murphy B. R.,
    5. Alling D. W.,
    6. Walsh E. E.,
    7. Collins P. L.
    Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.J. Virol.61198731633166
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Kneyber M. C.,
    2. Brandenburg A. H.,
    3. Rothbarth P. H.,
    4. de Groot R.,
    5. Ott A.,
    6. Van Steensel-Moll H. A.
    Relationship between clinical severity of respiratory syncytial virus infection and subtype.Arch. Dis. Child.751996137140
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. MacDonald N. E.,
    2. Hall C. B.,
    3. Suffin S. C.,
    4. Alexson C.,
    5. Harris P. J.,
    6. Manning J. A.
    Respiratory syncytial viral infection in infants with congenital heart disease.N. Engl. J. Med.3071982397400
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. McConnochie K. M.,
    2. Hall C. B.,
    3. Walsh E. E.,
    4. Roghmann K. J.
    Variation in severity of respiratory syncytial virus infections with subtype.J. Pediatr.11719905262
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. McIntosh E. D.,
    2. De Silva L. M.,
    3. Oates R. K.
    Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia.Pediatr. Infect. Dis. J.121993815819
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Monto A. S.,
    2. Ohmit S.
    Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965.J. Infect. Dis.1611990781783
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Mufson M. A.,
    2. Belshe R. B.,
    3. Orvell C.,
    4. Norrby E.
    Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981–1986.J. Infect. Dis.1571988143148
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Mulholland E. K.,
    2. Olinsky A.,
    3. Shann F. A.
    Clinical findings and severity of acute bronchiolitis.Lancet335199012591261
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Navas L.,
    2. Wang E.,
    3. de Carvalho V.,
    4. Robinson J.
    Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada.J. Pediatr.1211992348354
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Parrott R. H.,
    2. Kim H. W.,
    3. Arrobio J. O.,
    4. Hodes D. S.,
    5. Murphy B. R.,
    6. Brandt C. D.,
    7. Camargo E.,
    8. Chanock R. M.
    Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.Am. J. Epidemiol.981973289300
    OpenUrlPubMedWeb of Science
  27. 27.↵
    1. Peret T. C.,
    2. Hall C. B.,
    3. Schnabel K. C.,
    4. Golub J. A.,
    5. Anderson L. J.
    Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community.J. Gen. Virol.79199822212229
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Russi J. C.,
    2. Chiparelli H.,
    3. Montano A.,
    4. Etorena P.,
    5. Hortal M.
    Respiratory syncytial virus subgroups and pneumonia in children. (Letter and comment.) Lancet 2 1989 1039 1040
    OpenUrlPubMed
  29. 29.↵
    1. Salomon H. E.,
    2. Avila M. M.,
    3. Cerqueiro M. C.,
    4. Orvell C.,
    5. Weissenbacher M.
    Clinical and epidemiologic aspects of respiratory syncytial virus antigenic variants in Argentinian children. (Letter.) J. Infect. Dis. 163 1991 1167
    OpenUrlPubMed
  30. 30.↵
    1. Storch G. A.,
    2. Anderson L. J.,
    3. Park C. S.,
    4. Tsou C.,
    5. Dohner D. E.
    Antigenic and genomic diversity within group A respiratory syncytial virus.J. Infect. Dis.1631991858861
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Sullender W. M.,
    2. Mufson M. A.,
    3. Anderson L. J.,
    4. Wertz G. W.
    Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.J. Virol.65199154255434
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Sullender W. M.,
    2. Mufson M. A.,
    3. Prince G. A.,
    4. Anderson L. J.,
    5. Wertz G. W.
    Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children.J. Infect. Dis.1781998925932
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Taylor C. E.,
    2. Morrow S.,
    3. Scott M.,
    4. Young B.,
    5. Toms G. L.
    Comparative virulence of respiratory syncytial virus subgroups A and B. (Letter.) Lancet 1 1989 777 778
    OpenUrlPubMed
  34. 34.↵
    1. Tsutsumi H.,
    2. Onuma M.,
    3. Nagai K.,
    4. Yamazaki H.,
    5. Chiba S.
    Clinical characteristics of respiratory syncytial virus (RSV) subgroup infections in Japan.Scand. J. Infect. Dis.231991671674
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Van Milaan A. J.,
    2. Sprenger M. J.,
    3. Rothbarth P. H.,
    4. Brandenburg A. H.,
    5. Masurel N.,
    6. Class E. C.
    Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes.J. Med. Virol.4419948087
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Walsh E. E.,
    2. McConnochie K. M.,
    3. Long C. E.,
    4. Hall C. B.
    Severity of respiratory syncytial virus infection is related to virus strain.J. Infect. Dis.1751997814820
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Wang E. E.,
    2. Law B. J.,
    3. Stephens D.
    Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.J. Pediatr.1261995212219
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity
A. H. Brandenburg, R. van Beek, H. A. Moll, A. D. M. E. Osterhaus, E. C. J. Claas
Journal of Clinical Microbiology Oct 2000, 38 (10) 3849-3852; DOI: 10.1128/JCM.38.10.3849-3852.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity
A. H. Brandenburg, R. van Beek, H. A. Moll, A. D. M. E. Osterhaus, E. C. J. Claas
Journal of Clinical Microbiology Oct 2000, 38 (10) 3849-3852; DOI: 10.1128/JCM.38.10.3849-3852.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Genetic Variation
HN Protein
phylogeny
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus, Human
Viral Proteins

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X